148 F.4th 791
6th Cir.2025Background
- Dr. Robert O’Laughlin, a former radiation oncologist at Kentucky cancer centers, brought a qui tam action under the False Claims Act (FCA) alleging fraudulent Medicare billing by his former employers.
- Allegations included that radiation and chemotherapy services were billed as being supervised or performed by qualified physicians when, according to O'Laughlin, they were not.
- The district court dismissed O’Laughlin’s radiation-services claims at the pleadings stage and, after discovery, granted summary judgment for the defendants on the chemotherapy claims.
- O’Laughlin appealed, challenging both the partial dismissal and the summary judgment.
- The United States investigated and settled with one center but did not intervene in O’Laughlin’s remaining claims.
- O’Laughlin also pressed a conspiracy claim based on the same underlying facts.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether FCA liability exists for billing radiation services absent supervision by qualified physicians | Only radiation oncologists/radiologists may supervise or perform these services, so all bills lacking such oversight were fraudulent | Medicare rules do not mandate specialty for physician supervision; any qualified physician suffices | Court held that rules did not require the specific specialty O’Laughlin asserted; thus, noncompliance was not a material precondition for payment |
| Whether chemotherapy services were fraudulently billed as physician-performed when not actually performed/supervised by physicians | Analyzed schedules and records to infer that, at times, no physicians were present; bills thus false | Master Schedules unreliable; locum physicians did provide coverage; no direct proof of any specific fraudulent claim | No sufficient evidence of a false claim submitted; summary judgment for defendants |
| Whether reimbursement for Leukine injections given without physician supervision was fraud | Leukine administration is part of chemotherapy requiring supervision, thus bills were fraudulent without physician | Leukine is not a chemotherapy drug per code definitions and does not require physician oversight for administration | Court agreed Leukine is not a chemotherapy service under Medicare; claim fails |
| Whether conspiracy to submit false claims existed | Conspiracy evidenced by coordinated fraudulent billing | No underlying FCA violation proven; thus, no actionable conspiracy | Without a predicate FCA violation, conspiracy claim fails |
Key Cases Cited
- United States ex rel. Prather v. Brookdale Senior Living Cmtys., 838 F.3d 750 (6th Cir. 2016) (sets pleading standards for FCA violations)
- United States ex rel. Ibanez v. Bristol-Myers Squibb Co., 874 F.3d 905 (6th Cir. 2017) (requires a specific false claim for FCA liability)
- United States ex rel. Marlar v. BWXT Y-12, LLC, 525 F.3d 439 (6th Cir. 2008) (a fraudulent claim is the sine qua non of an FCA violation)
- United States ex rel. Bledsoe v. Cmty. Health Sys., Inc., 342 F.3d 634 (6th Cir. 2003) (details elements for FCA claims)
- Universal Health Servs., Inc. v. United States, 579 U.S. 176 (2016) (explains when regulatory noncompliance constitutes actionable fraud under FCA)